Microsoft word - recieved-dossiers-details1.doc

30 April 2004
Active substances in PT 8 and 14
for which at least one dossier was submitted by 28 March 2004
The following tables list those existing active substances, notification of which had been
accepted, within product types 8 and 14, and for which at least one dossier has been submitted
to the designated Rapporteur Member State.
Nota bene: The tables are made publicly available for information only. Publication does not
mean that the dossiers have been accepted as complete - verification of completeness is
currently ongoing.
Active substances for wood preservatives
Rapporteur
Name (EINECS and/or others) EC
Number CAS
Member State
Cyclohexylhydroxydiazene 1-oxide, potassium salt .kappa.O)diazeniumato(2-)]-copper 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2- (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl- 2-nitroguanidine 3-Iodo-2-propynyl butylcarbamate 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1- ylmethyl)pentan-3-ol / Tebuconazole Thiabendazole cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6- N-Didecyl-N-dipolyethoxyammonium borate / Didecylpolyoxethylammonium borate Copper oxide Copper(II) carbonate—copper(II) hydroxide (1:1) trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea / Flufenoxuron Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro- 3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2- methyl[1,1’-biphenyl]-3-ylmethyl ester, (1R,3R)-rel- / Bifenthrin / Biphenate Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N- (p-tolyl)methanesulphenamide / Tolyfluanid 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan- 2-yl]methyl]-1H-1,2,4-triazole / Propiconazole 30 April 2004
Active substances for wood preservatives
Rapporteur
Name (EINECS and/or others) EC
Number CAS
Member State
Quaternary ammonium compounds, benzyl-C12- 16-alkyldimethyl, chlorides Poly(oxy-1,2-ethanediyl), .alpha.-[2- (didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt) Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides) / BKC Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates) / DDAC Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and EINECS listed tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates) / TMAC m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2- dimethylcyclopropanecarboxylate / Permethrin 1-[2-(allyloxy)-2-(2,4-Dichlorophenyl)ethyl]-1H- N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine 4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5- Plant protection 122453-73-0 (trifluoromethyl)-1H-pyrrole-3-carbonitrile / Active substances for rodenticides
Rapporteur
Name (EINECS and/or others) EC
Number CAS
Member State
.alpha.,.alpha.,.alpha.-trifluoro-N-methyl-4,6- dinitro-N-(2,4,6-tribromophenyl)-o-toluidine / 30 April 2004
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)- 4-hydroxycoumarin / Difenacoum 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4- tetrahydro-1-naphthyl)coumarin / Brodifacoum Warfarin Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3- (4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin / Flocoumafen Chloralose 3-[3-(4'-bromo[1,1'-biphenyl]-4-yl)-3-hydroxy-1- phenylpropyl]-4-hydroxy-2-benzopyrone / Bromadiolone 3-(3-(4’-Bromo-(1,1’-biphenyl)-4-yl)-1,2,3,4- tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran- 2-one / 3-((RS,3RS;1RS,3SR)-3-(4'-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one / Difethialone

Source: http://www.holz-schuetzen.de/5_aktuell/files/qimt6930.pdf

Dawn of 2009 - peru

AN ORGANISATION FOR PROMOTING UNDERSTANDING OF SOCIETY "Peru and the World at the Dawn of 2009" Report of a Listening Post held in January Encouraging The Reflective Citizen Part 1. THE SHARING OF PREOCCUPATIONS AND EXPERIENCES In this part of the Listening Post participants were invited to identify, contribute, and explore their experience in their various social roles, b

dr.beaumont.edu

Beaumont forms hybrid research and device labBeaumont Health System plans to open one of the nation’s first hospital-based combination cardiovascular research and physician training centers at the Royal Oak campus this fall, as part of its mission as a center for medical education. The Beaumont Center for Innovation and Research in Cardiovascular Disease (CIRC) will conduct medical devic

© 2010-2017 Pharmacy Pills Pdf